Intelligence · Clinical Development
Pipeline search results
Programs matching “mesenchymal” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 37 pipeline programs matching "mesenchymal" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Mesenchymal Stromal Cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Graft-Versus-Host Disease
1 trial -
ALLOGENEIC AND EXPANDED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS
Lxo Ireland Designated Activity Company
Sars-CoV2
1 trial -
Adult Allogeneic Mesenchymal cells from adipose tissue.
Lxo Ireland Designated Activity Company
Acute Graft Versus Host Disease
1 trial -
Autologous adipose derived mesenchymal stem cells
Lxo Ireland Designated Activity Company
Critical Limb Ischemia (CLI)
1 trial -
Autologous mesenchymal stem cells from adipose tissue.
Lxo Ireland Designated Activity Company
Autoimmune Diseases
1 trial -
Bone marrow mesenchymal stem cells (low dose)
Sun Yat-sen University
Acute-On-Chronic Liver Failure
1 trial -
Bone marrow mesenchymal stem cells autologous
Lxo Ireland Designated Activity Company
Multiple Sclerosis
1 trial -
Human Mesenchymal Stromal Cells
United Therapeutics Europe Ltd
Respiratory Distress Syndrome, Adult
1 trial -
Infusion of mesenchymal stem cells from adipose tissue
Lxo Ireland Designated Activity Company
Faecal Incontinence
1 trial -
Injectable suspension of allogeneic adult mesenchymal stem cells
Lxo Ireland Designated Activity Company
Hidradenitis Suppurativa
1 trial -
Mesenchymal Stromal Cells
United Therapeutics Europe Ltd
Corneal Ulcer
1 trial -
Mesenchymal progenitor cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Knee Osteoarthritis
1 trial -
Mesenchymal stem cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hematopoietic Stem Cell Transplantation
1 trial -
Mesenchymal stem cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Graft-versus-host Disease
1 trial -
Mesenchymal stem cells for Systemic Sclerosis
Disc Medicine
Systemic Sclerosis
1 trial -
Mesenchymal stem cells from adipose tissue
Lxo Ireland Designated Activity Company
Critical Limb Ischemia
1 trial -
Umbilical Cord Mesenchymal Stem Cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Spinal Cord Injury
1 trial -
Umbilical Cord Mesenchymal Stem Cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Spinal Cord Injuries
2 trials -
allogeneic human mesenchymal stem cells (hMSCs)
United Therapeutics Europe Ltd
Non-ischemic Dilated Cardiomyopathy
1 trial -
autologous adipose-derived mesenchymal stem cell transplantation
Hospital Authority, Hong Kong
Aging Problems
1 trial -
autologous mesenchymal stem cells implantation
Teva Pharma GmbH
Tibial Fracture
1 trial -
mesenchymal stem cell
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lupus Nephritis
1 trial -
mesenchymal stem cell
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Kidney Transplant
1 trial -
umbilical cord mesenchymal stem cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Peripheral Arterial Disease
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.